Type 2 Diabetes Trial, Recruiting NCT07256613 Sponsor: Dow University of Health Sciences Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Recruiting

NCT07256613
Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Adults between 30 and 65 years of age.
  • People who have been diagnosed with type 2 diabetes for at least one year.
  • People whose diabetes is not well controlled, meaning their HbA1c blood sugar measure is 7% or higher.
  • People who have moderate to severe gum disease (confirmed by a dental examination).
  • People whose kidneys are functioning at an adequate level, based on a blood test result of 60 mL/min/1.73 m² or higher (confirm with trial site).
  • People who are willing and able to sign a written consent form agreeing to take part.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who are critically ill or who have difficulty communicating.
  • People who are pregnant or breastfeeding.
  • Women who have used hormone replacement therapy or oral contraceptives in the past six months.
  • People who have taken anti-inflammatory medications, such as steroids or common pain-relief drugs like ibuprofen, in the past three months (low-dose aspirin of up to 75 mg per day is an exception).
  • People who have recently experienced a significant blood loss, a serious physical injury, or bleeding in the digestive system.
  • People who have taken antibiotics within the past month.
  • People who have had a fever or vomiting lasting more than one week within the past month.
  • People who regularly use tobacco products or alcohol.
  • People who have another ongoing chronic illness or health condition that could affect the study results.
  • People who are unwilling or unable to follow the study procedures or attend follow-up visits.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +92-333-2685579

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Dow University of Health Sciences
Registry
ClinicalTrials.gov
Start date
15 August 2025
Est. completion
15 January 2026

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇵🇰 Pakistan

Primary endpoints

Change from Baseline in Serum Creatinine, Blood Urea Nitrogen, and Estimated Glomerular Filtration Rate (eGFR) at 90 Days After Non-Surgical Periodontal Therapy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov